Displaying 13 - 24 of 26
Liver Tumours
5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View
Liver Tumours
5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View
Liver Tumours
5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View
Liver Tumours
5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
Displaying 13 - 24 of 26